N-Nitroso Edoxaban Impurity 4
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs .N-Nitroso Edoxaban Impurity 4 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 4 chemically represented as 2-bromo-5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridine . Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 4 .We supply N-Nitroso Edoxaban Impurity 4 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-E39289 |
| CAS No | NA |
| Mol.F. | C9H12N2O2S |
| Mol.Wt. | 212.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39290 |
| CAS No | NA |
| Mol.F. | C9H9ClN2O3 |
| Mol.Wt. | 228.6g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39291 |
| CAS No | NA |
| Mol.F. | C27H30ClN9O5S |
| Mol.Wt. | 628.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39292 |
| CAS No | NA |
| Mol.F. | C7H11BrO3 |
| Mol.Wt. | 223.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39293 |
| CAS No | 138008-17-0 |
| Mol.F. | C7H11BrO3 |
| Mol.Wt. | 223.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39294 |
| CAS No | 2952824-27-8 |
| Mol.F. | C7H13NO3 |
| Mol.Wt. | 159.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39295 |
| CAS No | 2514919-76-5 |
| Mol.F. | C24H30ClN7O4S |
| Mol.Wt. | 548.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39296 |
| CAS No | 1824205-91-5 |
| Mol.F. | C14H27N3O3 |
| Mol.Wt. | 285.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39297 |
| CAS No | NA |
| Mol.F. | C26H47N5O6 |
| Mol.Wt. | 525.7g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39298 |
| CAS No | NA |
| Mol.F. | C33H50ClN7O8 |
| Mol.Wt. | 708.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39299 |
| CAS No | NA |
| Mol.F. | C39H50ClN11O6S2 |
| Mol.Wt. | 868.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39300 |
| CAS No | 1461714-66-8 |
| Mol.F. | C15H18N4OS2 |
| Mol.Wt. | 334.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39301 |
| CAS No | 139893-81-5 |
| Mol.F. | C7H9BrO2 |
| Mol.Wt. | 205.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39302 |
| CAS No | 2803372-97-4 |
| Mol.F. | C24H31N7O4S |
| Mol.Wt. | 513.6g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39303 |
| CAS No | NA |
| Mol.F. | C23H27Cl2N7O4 |
| Mol.Wt. | 536.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39304 |
| CAS No | 929693-30-1 |
| Mol.F. | C14H26N2O4 |
| Mol.Wt. | 286.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |